PHILADELPHIA, April 23, 2014 /PRNewswire/ -- Stanson's next-generation clinical decision support and analytics solution fully integrates into EMRs, provides alerts to help providers keep care costs low, quality highElsevier, a world-leading provider of scientific, technical and medical information products and services, announced today an agreement to market Stanson Health's next-generation clinical decision support (CDS) and analytics solution. Stanson's CDS solutions are designed to safely reduce the cost and potential for harm from unnecessary care by leveraging user-friendly, real-time alerts and analytics to help guide physicians' decisions. Stanson's CDS solutions complement the Elsevier Clinical Solutions suite, which includes a portfolio of solutions for workflow and decision support, clinical reference and drug reference, patient engagement and performance management. As the healthcare industry evolves, healthcare payers (i.e., insurance companies, the government) are counting on physicians and hospitals to control and even reduce costs as they improve the quality of care. Unnecessary or inappropriate care accounts for a significant amount of the overall healthcare spend, and more than 80 percent of overall healthcare costs are directly linked to decisions made by physicians. Stanson Health, a population health, CDS and analytics company, provides previously tested and validated CDS alerts, which reduce the potential for "false positive" alerts that cause alert fatigue. The alerts are designed to reduce unnecessary care for patient populations across the continuum, in physician offices, emergency departments and hospitals. The CDS recommendations are based on widely accepted guidelines, including from Choosing Wisely®, an initiative of the ABIM Foundation. The analytics solution provides comparative information on physician acceptance and rejection of CDS recommendations and provides "utilization fingerprints" that are used to inform discussions about high quality and cost-effective care. "With the transition toward population health and payment reform, and the improvement in EHR functionality, we believe that there is need for the next generation of CDS," said Scott Weingarten, MD, Chairman of Stanson Health. "The CDS should be integrated into the workflow, personalized for each patient, accompanied by analytics and tested prior to release to reduce false-positives, impact care across the continuum, safely reduce costs and improve quality." Weingarten was the co-founder and CEO of Zynx Health for 16 years. Stanson Health's CDS and analytics solution was first implemented at Cedars-Sinai Health System, where it demonstrated statistically significant improvements in the quality of patient care and reductions in inappropriate care.